pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 13·1 min read
save

Trump administration seeks new FDA commissioner to restore trust, prioritize food policy and accelerate drug approvals

May 13, 2026·read at STAT ↗RegulatoryNeutral

The Trump administration is moving quickly to name a successor to FDA commissioner Marty Makary, who resigned.

Officials say the search will take several weeks and they are looking for a leader who can rebuild trust with agency staff.

Key priorities include strengthening the FDA’s food safety role and continuing reforms aimed at speeding up drug approvals.

No shortlist of candidates has been disclosed, and lobbyists are speculating but the administration has not confirmed any names.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: What the Trump administration wants in its next FDA leader”

read at STAT ↗
617 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
topics
Gene Therapy (AAV)3Approval2Oncology2OphthalmologyRare Disease

related stories

  • Sep 3Capricor, Replimune illustrate why FDA must listen to rare disease specialistsBioSpace
  • Jul 27Sarepta names former AbbVie R&D exec Michael Severino as next CEOBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 23Fierce Biotech Layoff Tracker 2026: Caribou cuts staff, halts pipeline; Foghorn reduces workforce by 40%Fierce Biotech
  • 2d agoCaribou layoffs could wipe out 90% of staffBioSpace